Pfizer Global Medical Grants Inflammatory Bowel Disease RFP

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: Monday 27th, June 2022

External Deadline: Thursday 30th, June 2022


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP). Institutions are invited to submit an application as outlined in the specific RFP.

This RFP reflects Pfizer’s commitment to advancing research, innovation, and training for medical, nursing, and allied health professionals.

Geographic Scope: Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey

Clinical Area: Inflammatory Bowel Disease

Link to full RFP: Inflammatory Bowel Disease

Application Due Date: June 30, 2022

Specific Area of Interest: 
Through this grant programme, we intend to support research and clinical training fellowship programmes in regions where there are continued workforce challenges in relation to the management of IBD patients.

Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Ai Ping Lee (

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: May 16, 2022